A phase II, open-label study to evaluate the antiviral activity, safety, tolerability of emivirine (EMV, MKC-442) with stavudine (d4T) + didanosine (ddI).
Originally Published on February 1, 2000
Johnson, D., Sanne, I., Baraldi, E., Van Der Westhuizen, I., Grimwood, A., Sole, T., Zeier, M., Steyn, D., Kargl, D., Fang, L., Quinn, J., Moxham, C., and Rousseau, F.
39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26-29, 1999. Abstract 502.
